These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 1685993

  • 1. Comparison of the effects of xamoterol, atenolol and propranolol on breathlessness, fatigue and plasma electrolytes during exercise in healthy volunteers.
    Sørensen EV, Jensen HK, Faergeman O.
    Eur J Clin Pharmacol; 1991; 41(1):51-5. PubMed ID: 1685993
    [Abstract] [Full Text] [Related]

  • 2. Effects of selective beta 2-adrenoceptor blockade on serum potassium and exercise performance in normal men.
    Gullestad L, Birkeland K, Nordby G, Larsen S, Kjekshus J.
    Br J Clin Pharmacol; 1991 Aug; 32(2):201-7. PubMed ID: 1681847
    [Abstract] [Full Text] [Related]

  • 3. Effect of beta-adrenoceptor agents on the blood flow in carotid arteries in normal volunteers.
    Fitzgerald DE, Harry JD.
    Br J Clin Pharmacol; 1989 Aug; 28 Suppl 1(Suppl 1):73S-74S. PubMed ID: 2572260
    [Abstract] [Full Text] [Related]

  • 4. beta(2) and beta(3)-adrenoceptor inhibition of alpha(1)-adrenoceptor-stimulated Ca(2+) elevation in human cultured prostatic stromal cells.
    Haynes JM.
    Eur J Pharmacol; 2007 Sep 10; 570(1-3):18-26. PubMed ID: 17617401
    [Abstract] [Full Text] [Related]

  • 5. A comparative study on the ventilatory and haemodynamic effects of xamoterol and atenolol in asthmatic patients.
    Lammers JW, Müller ME, Folgering HT, van Herwaarden CL.
    Br J Clin Pharmacol; 1986 Nov 10; 22(5):595-602. PubMed ID: 2878680
    [Abstract] [Full Text] [Related]

  • 6. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
    Hicks PE, Cavero I, Manoury P, Lefevre-Borg F, Langer SZ.
    J Pharmacol Exp Ther; 1987 Sep 10; 242(3):1025-34. PubMed ID: 2888869
    [Abstract] [Full Text] [Related]

  • 7. Effects of ICI 141,292 on exercise tachycardia and isoprenaline-induced beta-adrenoceptor responses in man.
    Pringle TH, O'Connor PC, McNeill AJ, Finch MB, Riddell JG, Shanks RG.
    Br J Clin Pharmacol; 1986 Mar 10; 21(3):249-58. PubMed ID: 2870732
    [Abstract] [Full Text] [Related]

  • 8. Metabolic, electrocardiographic, and hemodynamic responses to increased circulating adrenaline: effects of selective and nonselective beta adrenoceptor blockade.
    Hansen O, Johansson BW, Nilsson-Ehle P.
    Angiology; 1990 Mar 10; 41(3):175-88. PubMed ID: 1968731
    [Abstract] [Full Text] [Related]

  • 9. Differentiation of hemodynamic, humoral and metabolic responses to beta 1- and beta 2-adrenergic stimulation in man using atenolol and propranolol.
    McLeod AA, Brown JE, Kuhn C, Kitchell BB, Sedor FA, Williams RS, Shand DG.
    Circulation; 1983 May 10; 67(5):1076-84. PubMed ID: 6299612
    [Abstract] [Full Text] [Related]

  • 10. Selective beta-adrenoceptor partial agonist effects of pindolol and xamoterol on skeletal muscle assessed by plasma creatine kinase changes in healthy subjects.
    Tomlinson B, Cruickshank JM, Hayes Y, Renondin JC, Lui JB, Graham BR, Jones A, Lewis AD, Prichard BN.
    Br J Clin Pharmacol; 1990 Nov 10; 30(5):665-72. PubMed ID: 1980200
    [Abstract] [Full Text] [Related]

  • 11. Effects of beta 1-selective and nonselective beta-adrenoceptor blockade during exercise conditioning in healthy adults.
    McLeod AA, Kraus WE, Williams RS.
    Am J Cardiol; 1984 Jun 01; 53(11):1656-61. PubMed ID: 6375340
    [Abstract] [Full Text] [Related]

  • 12. An assessment of the partial agonist activity of Ro 31-1118, flusoxolol and pindolol in man.
    McCaffrey PM, Riddell JG, Shanks RG.
    Br J Clin Pharmacol; 1987 Nov 01; 24(5):571-80. PubMed ID: 2893634
    [Abstract] [Full Text] [Related]

  • 13. Facilitation of calcium blocking and membrane effects by intrinsic sympathomimetic activity.
    Smith HJ, Halliday SE, Briscoe MG, Snow HM.
    Cardiovasc Res; 1984 Jan 01; 18(1):30-6. PubMed ID: 6141007
    [Abstract] [Full Text] [Related]

  • 14. Observations on the mechanism underlying the differences in exercise and isoprenaline tachycardia after cardioselective and non-selective beta-adrenoceptor antagonists.
    McGibney D, Singleton W, Silke B, Taylor SH.
    Br J Clin Pharmacol; 1983 Jan 01; 15(1):15-9. PubMed ID: 6849739
    [Abstract] [Full Text] [Related]

  • 15. Effect of xamoterol on peripheral blood vessels in healthy subjects.
    Fitzgerald DE.
    Br J Clin Pharmacol; 1989 Jan 01; 28 Suppl 1(Suppl 1):70S-72S. PubMed ID: 2572259
    [Abstract] [Full Text] [Related]

  • 16. Agonist-induced desensitization of beta-adrenoceptor function in humans. Subtype-selective reduction in beta 1- or beta 2-adrenoceptor-mediated physiological effects by xamoterol or procaterol.
    Brodde OE, Daul A, Michel-Reher M, Boomsma F, Man in 't Veld AJ, Schlieper P, Michel MC.
    Circulation; 1990 Mar 01; 81(3):914-21. PubMed ID: 1968366
    [Abstract] [Full Text] [Related]

  • 17. Beta-adrenoceptor blockade and hypoglycaemia. A randomised, double-blind, placebo controlled comparison of metoprolol CR, atenolol and propranolol LA in normal subjects.
    Kerr D, MacDonald IA, Heller SR, Tattersall RB.
    Br J Clin Pharmacol; 1990 Jun 01; 29(6):685-93. PubMed ID: 1974143
    [Abstract] [Full Text] [Related]

  • 18. Human pharmacokinetic and pharmacodynamic studies on the atenolo (ICI 66,082), a new cardioselective beta-adrenoceptor blocking drug.
    Conway FJ, Fitzgerald JD, McAinsh J, Rowlands DJ, Simpson WT.
    Br J Clin Pharmacol; 1976 Apr 01; 3(2):267-72. PubMed ID: 973955
    [Abstract] [Full Text] [Related]

  • 19. Evidence for cardiac beta 2-adrenoceptors in man.
    Brown JE, McLeod AA, Shand DG.
    Clin Pharmacol Ther; 1983 Apr 01; 33(4):424-8. PubMed ID: 6299641
    [Abstract] [Full Text] [Related]

  • 20. The effects of selective beta-adrenoceptor antagonists and partial agonist activity on renal function during exercise in normal subjects and those with moderate renal impairment.
    Taverner D, Mackay IG, Craig K, Watson ML.
    Br J Clin Pharmacol; 1991 Sep 01; 32(3):387-91. PubMed ID: 1685667
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.